AstraZeneca Pharma India Limited(IN:ASTRAZEN)
₹6,511.10-1.10 (-0.02%)
IN:ASTRAZEN
AstraZeneca Pharma India Limited Revenue
₹6,511.10
At close:-1.10 (-0.02%)
Want to see IN:ASTRAZEN full AI Analyst Report?
AstraZeneca Pharma India Limited (ASTRAZEN) Revenue
44 Followers
AstraZeneca Pharma India Limited Revenue
AstraZeneca Pharma India Limited had a revenue of 6.83B in the quarter ending Jun 30, 2026, with 18.01%. This bring the company's revenue in the last twelve months to 24.32B, Increased 6.88%. In the fiscal year ending Mar 31, 2026, AstraZeneca Pharma India Limited had annual revenue of 22.76B with 32.82% growth.
- Revenue (ttm)
- 24.32B
- Revenue Growth
- 29.70%
- P/S Ratio
- 7.15
- Revenue/Employee
- INR 29,941,842
- Employees
- 760
- Market Cap
- INR 162.81B
Revenue Chart
AstraZeneca Pharma India Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 22.76B | 5.62B | 32.82% |
| Mar 31, 2025 | 17.13B | 4.18B | 32.25% |
| Mar 31, 2024 | 12.96B | 2.93B | 29.17% |
| Mar 31, 2023 | 10.03B | 1.97B | 24.50% |
| Mar 31, 2022 | 8.06B | -29.60M | -0.37% |
| Mar 31, 2021 | 8.09B | -232.10M | -2.79% |
| Mar 31, 2020 | 8.32B | 1.25B | 17.66% |
| Mar 31, 2019 | 7.07B | 1.36B | 23.81% |
| Mar 31, 2018 | 5.71B | 273.10M | 5.02% |
| Mar 31, 2017 | 5.44B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:ASTRAZEN | 24.32B |
| IN:DRREDDY | 329.84B |
| IN:GLENMARK | 169.83B |
| IN:LUPIN | 299.00B |
| IN:SUNPHARMA | 616.31B |
| IN:TORNTPHARM | 173.48B |